Wendall Wierenga, Director at Ocera Therapeutics, Inc. (OCRX), bought 5,000 shares at $3.71 ($19K) on 2015-06-23, disclosed to the SEC on 2015-06-24.
Open-market purchase of $19k OCRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| CYTK | SELL | 2024-11-26 | $37K | — | Filing → |
| CYTK | SELL | 2024-10-31 | $233K | — | Filing → |
| CYTK | SELL | 2023-12-27 | $368K | — | Filing → |